Oral Dosage Form New Animal Drugs; Oxytetracycline Hydrochloride Soluble Powder

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by I.D. Russell Co. Laboratories under the National Academy of Sciences/National Research Council, Drug Efficacy Study Implementation Program. The supplemental NADA provides for expanding the ``me-too'' use of oxytetracycline hydrochloride (OTC HCl) soluble powder to the drinking water of swine for the control and treatment of bacterial enteritis, bacterial pneumonia and leptospirosis.